mRNA for NGF and p75 in the central nervous system of rats affected by experimental allergic encephalomyelitis

Neuropathology and Applied Neurobiology

Volumn 22, Issue 1, 1996, Pages 54-59

  De Simone, R ^a   Micera, A ^a   Tirassa, P ^a   Aloe, L ^a  

^a CNR   (Italy)

Author keywords

Central nervous system; Experimental allergic encephalomyelitis; Multiple sclerosis; Myelin basic protein; Nerve growth factor; Nerve growth factor receptor (p75)

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ACUTE PHASE RESPONSE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; THALAMUS; TIME;

EID: 0030041772     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1996.tb00846.x     Document Type: Article

References (27)

1. Aloe L, Skaper SD, Leon A, Levi-Montalcini R. Nerve growth factor and autoimmune disease. Autoimmunity 1994; 19: 141-50
2. Aloe L, Levi-Montalcini R. Mast cells increase in tissue of neonatal rats injected with nerve growth factor. Brain Res 1977; 133: 358-66
3. Bauer J, Berkenbosch F, Van-Dam AM, DijKstra CD. Demonstration of interleukin-1B in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastruclural level. J Neuroimmunol 1993; 48: 13-22
4. Bo L, Olsson T, Nyland H, Kruger PG, Taule A, Mork S. Mast cells in brains during experimental allergic encephalomyelitis. J Neurol Sci 1991; 105: 135-42
5. Bracci-Laudiero L, Aloe L, Levi-Montalcini R et al. Multiple sclerosis patients express increased levels of B-nerve growth factor in cerebrospinal fluid. Neurosci Lett 1992; 147: 9-12
6. Brodie C, Gelfand EW. Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J Immunol 1992; 148: 3492-7
7. Byravan S, Foster LM, Phan T, Verity AN, Campagnoni AT. Murine oligodendroglial cells express nerve growth factor. Proc Natl Acad Sci USA 1994; 91: 8812-16
8. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9
9. Cross AH, Cannella B, Brosnan CF, Raine CS. Hypothesis: antigen-specific T cells prime central nervous system endothelium for recruitment of nonspecific inflammatory cells to effect autoimmune demyelination. J Neuroimmunol 1991; 33: 237-14
10. DiStefano, PS. Neurotrophic factors in the treatment of motor neuron disease and trauma. Exp Neurology 1993; 124: 56-9
11. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase TrK in activated CD4-positive T-cell clones. Proc Natl Acad Sci 1993; 90: 10984-8
12. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A. On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur J Immunol 1989; 19: 689-94
13. Fusco M, Bentivoglio M, Vantini G, Guidolin D, Potato P, Leon A. Nerve growth factor receptor-immunoreactive libres innervate the reticular thalamic nucleus: modulation by nerve growth factor treatment in neonate, adult and aged rats. Eur J Neurosci 1991; 3:1008-15
14. Gadient RA, Cron KC, Otten, U. Interleukin-1B and tumor necrosis factor-α sinergistically stimulate nerve growth factor (NGF) release from culture rat astrocytes. Neurosci Lett 1990; 117: 335-40
15. Hofman FM, Hinton DR, Johnson K, Merril JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170: 607-12
16. Horigome K, Bullock ER, Johnson Jr EM. Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem 1994; 269: 2695-702
17. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992; 149: 2496-505
18. Lazar LM, Blum M. Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-α mRNA in mouse brain by a quantitative nuclease protection assay. J Neurosci 1992; 12: 1688-97
19. Leon A, Buriani A, Dal Toso et al. Mast cells synthesize, store and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91: 3793
20. Levi-Montalcini R, Aloe L, Alleva E. A role for nerve growth factor in nervous, endocrine and immune system. Prog Neuro Endocrin Immunol 1990; 1: 1-10
21. Lublin FD. Susceptibility to experimental allergic encephalomyelitis in animals models of autoimmunity. Curr Opin Neurol Neurosurg 1992; 5: 182-7
22. Micera A, De Simone R, Aloe L. Elevated levels of nerve growth factor in the thalamus and spinal cord of rats affected by experimental allergic encephalomyelitis. Arch Ital Biol 1995; 133: 131-42
23. Raine CS. Biology of disease: analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984; 50: 608-36
24. Thoenen H, Bandtlow C, Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev Physiol Biochem Pharmacol 1987; 109: 146-71
25. Tsukada N, Miyagi K, Matsuda M, Yanagisawa N, Yone K. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J Neurol Sci 1991; 102: 230-4
26. Tuveri MA, Passiu G, Mathieu A, Aloe L. Nerve growth factor and mast cells distribution in the skin of patients with systemic sclerosis. Clin Exp Rheum 1993; 11: 319-22
27. Van Q, Miller JA. The use of trophic factors in degenerative motoneurons diseases. Exp Neurol 1993; 124: 60-3